TriSalus Life Sciences Inc. (TLSI) — Cash Flow-to-Debt Ratio
TriSalus Life Sciences Inc. (TLSI) has a Cash Flow-to-Debt Ratio of -0.06x as of September 2025, meaning its operating cash flow of $-3.71 Million could theoretically repay 0% of its total liabilities ($63.19 Million) in one year. Check TriSalus Life Sciences Inc. earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
TriSalus Life Sciences Inc. Cash Flow-to-Debt Ratio (2021–2024)
Historical debt coverage capacity for TriSalus Life Sciences Inc. across 4 annual periods. Also explore TLSI asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for TriSalus Life Sciences Inc. (2021–2024)
Year-by-year debt coverage analysis for TriSalus Life Sciences Inc.. For market capitalisation and broader financial context, see TLSI market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.82x | $-40.84 Million | $49.87 Million | ▲ +16.3% |
| 2023 | -0.98x | $-50.58 Million | $51.66 Million | ▼ -4.0% |
| 2022 | -0.94x | $-32.31 Million | $34.32 Million | ▲ +71.2% |
| 2021 | -3.27x | $-22.70 Million | $6.93 Million | — |